Astro-Rad

Context

Astro-Rad is a wearable radiation-shielding vest developed by Israeli company StemRad, with support from the Israel Space Agency and collaboration with Lockheed Martin.
Astro-Rad was tested during NASA’s Artemis I mission in 2022 through the Matroshka Astro-Rad Radiation Experiment (MARE).

Astro-Rad: A wearable vest designed to reduce radiation exposure to the body’s most vulnerable organs and tissues.
Its main purpose is to provide personal radiation protection during deep-space travel.

The MARE experiment used two female-shaped manikins, Zohar and Helga.
Zohar wore Astro-Rad, while Helga did not, creating a direct comparison.
Radiation detectors measured dose levels at different locations inside the simulated bodies.
The experiment generated real deep-space data on the performance of wearable shielding.

Beyond LEO, astronauts face solar particle events (SPEs) and galactic cosmic rays (GCRs).
High exposure can cause radiation sickness and increase long-term risks such as cancer and tissue damage.
The danger rises during longer missions to the Moon and Mars.

Space radiation → hydrogen-rich shielding slows charged particles → lower dose reaches sensitive organs

Astro-Rad uses a hydrogen-rich polymer, which is effective against charged particles such as protons.
Different body regions receive different shielding thicknesses according to their radiation sensitivity.
Scale-like shielding elements allow protection while preserving body movement.
This selective design reduces the total mass compared with shielding the whole body equally.

Longer human missions: Better radiation control can support safer journeys beyond Earth orbit.
Mission continuity: Wearable protection may allow astronauts to continue essential activities during some radiation events.
Mass advantage: Personal shielding can reduce the need to add heavy protection across the entire spacecraft.
Technology convergence: Astro-Rad brings together material science, biomedical risk assessment and wearable engineering.

Human-spaceflight preparedness: Gaganyaan can help India build experience in radiation monitoring and astronaut health.
Future deep-space need: Crewed lunar missions will require stronger protection than short-duration LEO missions.
Technology opportunity: India can develop hydrogen-rich materials, dosimeters and wearable shielding systems.
Institutional capability: Cooperation among ISRO, medical institutions and material-science laboratories can strengthen space-medicine research.

Incomplete protection: A vest cannot shield every part of the body from all radiation.
GCR challenge: Galactic cosmic rays are highly energetic and especially difficult to block.
Comfort issue: More shielding can increase weight and reduce ease of movement.
Event dependence: Astro-Rad is more suited to reducing some radiation risks, especially solar-particle exposure, than solving the full deep-space radiation problem.

Develop lighter and more flexible radiation-shielding materials.
Improve real-time radiation forecasting and monitoring for crewed missions.
Expand research on long-term biological effects of deep-space radiation.
Test integrated protection systems combining personal shielding, spacecraft design and emergency shelters.

1. What is AstroRad?

It is a wearable radiation-shielding vest for astronauts travelling beyond Low-Earth Orbit.

2. Why does AstroRad use hydrogen-rich material?

Hydrogen is effective at slowing charged particles such as protons.

3. Does AstroRad protect against all space radiation?

No. It reduces exposure but cannot completely block all forms of radiation.

4. Where was AstroRad tested?

It was tested during NASA’s Artemis I mission in 2022.

5. What is the main UPSC takeaway?

AstroRad shows how selective, wearable shielding can reduce deep-space radiation risk while complementing other spacecraft protection systems.